AI-generated summary
The authors evaluated transcranial photobiomodulation in a mouse model of chronic cerebral hypoperfusion caused by bilateral carotid artery stenosis. They report improved cognitive performance and regional cerebral blood flow, along with reduced neuronal loss, though residual necrotic foci persisted. The authors describe these findings as supportive but call for longitudinal and mechanistic studies to define therapeutic parameters.
- Who or what was studied
- Mice with a bilateral common carotid artery stenosis model of chronic cerebral hypoperfusion
- Limits stated in the abstract
- The study is an animal model, and the abstract states that longitudinal and mechanistic studies are needed to define therapeutic parameters.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Cerebral blood flow, Photobiomodulation, Near-infrared, Transcranial photobiomodulation, Cognitive decline. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.